Richard Aldrich

Director, Altus Pharmaceuticals Inc.

Companies

CONCERT PHARMACEUTICALS, INC.Board member Feb 12, 2014 to Mar 6, 2023¹
Tempest Therapeutics, Inc.Board member Jun 11, 2012 to Dec 11, 2018²
KalVista Pharmaceuticals, Inc.Board member Nov 29, 2016 to Oct 5, 2018³
PTC TherapeuticsBoard member Jun 19, 2013 to Jun 10, 2015⁴
Verastem OncologyBoard member Jan 26, 2012 to Jun 11, 2014⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

CONCERT PHARMACEUTICALS, INC.0 shares⁶Mar 6, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Mar 6, 2023U 44,351 shares of CONCERT PHARMACEUTICALS, INC.⁶
Mar 6, 2023U 210,526 shares of CONCERT PHARMACEUTICALS, INC.⁶
Mar 6, 2023Returned to company 16,400 shares of CONCERT PHARMACEUTICALS, INC.⁶
Mar 6, 2023U 342,100 shares of CONCERT PHARMACEUTICALS, INC.⁶
Jun 9, 2022Granted 16,400 shares of CONCERT PHARMACEUTICALS, INC.⁷
Jun 6, 2022Bought 210,526 shares at $4.75 of CONCERT PHARMACEUTICALS, INC.⁸

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARCONCERT PHARMACEUTICALS, INC., Board member
2
SEC EDGARTempest Therapeutics, Inc., Board member
3
SEC EDGARKalVista Pharmaceuticals, Inc., Board member
4
SEC EDGARPTC Therapeutics, Board member
5
SEC EDGARVerastem Oncology, Board member
6
SEC EDGARCONCERT PHARMACEUTICALS, INC. shares after the filing of Mar 6, 2023
7
SEC EDGARForm 4 filed Jun 13, 2022
8
SEC EDGARForm 4 filed Jun 6, 2022